Skip to main content
Top
Published in: Clinical Rheumatology 5/2009

01-05-2009 | Brief Report

Spatial-temporal parameters of gait in women with fibromyalgia

Authors: José María Heredia Jiménez, Virginia A. Aparicio García-Molina, Jesús M. Porres Foulquie, Manuel Delgado Fernández, Victor M. Soto Hermoso

Published in: Clinical Rheumatology | Issue 5/2009

Login to get access

Abstract

The aim of the present study was to determine if there are differences in such parameters among patients affected by fibromyalgia (FM) and healthy subjects and whether the degree of affectation by FM can decrease the gait parameters. We studied 55 women with FM and 44 controls. Gait analysis was performed using an instrumented walkway for measurement of the kinematic parameters of gait (GAITRite system), and patients completed a Spanish version of Fibromyalgia Impact Questionnaire (FIQ). Significant differences (p < 0.001) between FM and control groups were found in velocity, stride length, cadence, single support ratio, double support ratio, stance phase ratio, and swing phase ratio. There were significant inverse correlations between FIQ and velocity, stride length, swing phase, and single support, whereas significant direct correlations were found with stance phase and double support. Gait parameters of women affected by FM were severely impaired when compared to those of healthy women. Different factors such as lack of physical activity, bradikinesia, overweight, fatigue, and pain together with a lower isometric force in the legs can be responsible for the alterations in gait and poorer life quality of women with FM.
Literature
1.
go back to reference Pierrynowskia MR, Tiidusb PM, Galea V (2005) Women with fibromyalgia walk with an altered muscle synergy. Gait Posture 22:210–218CrossRef Pierrynowskia MR, Tiidusb PM, Galea V (2005) Women with fibromyalgia walk with an altered muscle synergy. Gait Posture 22:210–218CrossRef
2.
go back to reference Maquet D, Croisier J, Renard C, Crielaard J (2002) Muscle performance in patients with fibromyalgia. Joint Bone Spine 69:293–299PubMedCrossRef Maquet D, Croisier J, Renard C, Crielaard J (2002) Muscle performance in patients with fibromyalgia. Joint Bone Spine 69:293–299PubMedCrossRef
3.
go back to reference Bendtsen L, Norregaard J, Jensen R, Olesen J (1997) Evidence of qualitatively altered nociception in patients with fibromyalgia. Arthritis Rheum 40:98–102PubMedCrossRef Bendtsen L, Norregaard J, Jensen R, Olesen J (1997) Evidence of qualitatively altered nociception in patients with fibromyalgia. Arthritis Rheum 40:98–102PubMedCrossRef
4.
go back to reference Auvinet B, Bileckot R, Alix AS, Chaleil D, Barrey E (2006) Gait disorders in patients with fibromyalgia. Joint Bone Spine 73:543–546PubMedCrossRef Auvinet B, Bileckot R, Alix AS, Chaleil D, Barrey E (2006) Gait disorders in patients with fibromyalgia. Joint Bone Spine 73:543–546PubMedCrossRef
5.
go back to reference Pankoff B, Overend T, Lucy D, White K (2000) Validity and responsiveness of the 6 minute walk test for people with fibromyalgia. J Rheumatol 27:2666–2670PubMed Pankoff B, Overend T, Lucy D, White K (2000) Validity and responsiveness of the 6 minute walk test for people with fibromyalgia. J Rheumatol 27:2666–2670PubMed
6.
go back to reference Mannerkorpi K, Nyberg B, Ahlmen M, Ekdahl C (2000) Pool exercise combined with an education program for patients with fibromyalgia syndrome. A prospective, randomized study. J Rheumatol 27:2473–2481PubMed Mannerkorpi K, Nyberg B, Ahlmen M, Ekdahl C (2000) Pool exercise combined with an education program for patients with fibromyalgia syndrome. A prospective, randomized study. J Rheumatol 27:2473–2481PubMed
7.
go back to reference Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL et al (1990) The american college of rheumatology 1990 criteria for the classification of fibromyalgia. Arthritis Rheum 33:160–172PubMedCrossRef Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL et al (1990) The american college of rheumatology 1990 criteria for the classification of fibromyalgia. Arthritis Rheum 33:160–172PubMedCrossRef
8.
go back to reference Ashwini KR, Lori Q, Karen SM (2005) Reliability of spatiotemporal gait outcome measures in Huntington’s disease. Mov Disord 20:1033–1037CrossRef Ashwini KR, Lori Q, Karen SM (2005) Reliability of spatiotemporal gait outcome measures in Huntington’s disease. Mov Disord 20:1033–1037CrossRef
9.
go back to reference Rivera J, González T (2004) The fibromyalgia impact questionnaire: a validated Spanish version to assess the health status in women with fibromyalgia. Clin Exp Rheumatol 22:554–560PubMed Rivera J, González T (2004) The fibromyalgia impact questionnaire: a validated Spanish version to assess the health status in women with fibromyalgia. Clin Exp Rheumatol 22:554–560PubMed
10.
go back to reference Kaufman KR, Chambers HG, Sutherland DH (1996) Variability of temporal distance measurements in pathological gait studies. Gait Posture 4:169CrossRef Kaufman KR, Chambers HG, Sutherland DH (1996) Variability of temporal distance measurements in pathological gait studies. Gait Posture 4:169CrossRef
11.
go back to reference Bilney B, Morris M, Webster K (2003) Concurrent related validity of the GAITRite walkway system for quantification of the spatial and temporal parameters of gait. Gait Posture 17:68–74PubMedCrossRef Bilney B, Morris M, Webster K (2003) Concurrent related validity of the GAITRite walkway system for quantification of the spatial and temporal parameters of gait. Gait Posture 17:68–74PubMedCrossRef
12.
go back to reference McDonough AL, Batavia M, Chen FC, Kwon S, Ziai J (2001) The validity and reliability of the GAITRite system’s measurements: a preliminary evaluation. Arch Phys Med Rehabil 82:419–425PubMedCrossRef McDonough AL, Batavia M, Chen FC, Kwon S, Ziai J (2001) The validity and reliability of the GAITRite system’s measurements: a preliminary evaluation. Arch Phys Med Rehabil 82:419–425PubMedCrossRef
13.
go back to reference Valkeinen H, Häkkinen A, Alen M, Hannonen P, Kukkonen-Harjula K, Häkkinen K (2007) Physical fitness in postmenopausal women with fibromyalgia. Int J Sports Med 29:408–413PubMedCrossRef Valkeinen H, Häkkinen A, Alen M, Hannonen P, Kukkonen-Harjula K, Häkkinen K (2007) Physical fitness in postmenopausal women with fibromyalgia. Int J Sports Med 29:408–413PubMedCrossRef
14.
go back to reference Gowans SE, deHueck A (2007) Pool exercise for individuals with fibromyalgia. Curr Opin Rheumatol 19:168–173PubMedCrossRef Gowans SE, deHueck A (2007) Pool exercise for individuals with fibromyalgia. Curr Opin Rheumatol 19:168–173PubMedCrossRef
15.
go back to reference Rooks DS, Silverman CB, Kantrowitz FG (2002) The effects of progressive strength training and aerobic exercise on muscle strength and cardiovascular fitness in women with fibromyalgia: a pilot study. Arthritis Rheum 47:22–28PubMedCrossRef Rooks DS, Silverman CB, Kantrowitz FG (2002) The effects of progressive strength training and aerobic exercise on muscle strength and cardiovascular fitness in women with fibromyalgia: a pilot study. Arthritis Rheum 47:22–28PubMedCrossRef
Metadata
Title
Spatial-temporal parameters of gait in women with fibromyalgia
Authors
José María Heredia Jiménez
Virginia A. Aparicio García-Molina
Jesús M. Porres Foulquie
Manuel Delgado Fernández
Victor M. Soto Hermoso
Publication date
01-05-2009
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 5/2009
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-009-1101-7

Other articles of this Issue 5/2009

Clinical Rheumatology 5/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.